Simon Dumesnil's Insider Trades & SAST Disclosures

Simon Dumesnil's most recent trade in Pasithea Therapeutics Corp was a trade of 7,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 1, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Pasithea Therapeutics Corp
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 7,500 7,500 - - Stock Option (right to buy)
Pasithea Therapeutics Corp
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 100,000 100,000 - - Stock Option (to acquire Common Stock)
Pasithea Therapeutics Corp
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 1.06 per share. 15 Nov 2022 40,000 50,000 - 1.1 42,400 Common Stock
Pasithea Therapeutics Corp
Simon Dumesnil Director Grant, award, or other acquisition of securities at price $ 1.07 per share. 15 Nov 2022 10,000 10,000 - 1.1 10,700 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades